AbbVie buys immuno-oncology firm Mavupharma — Boehringer buying cancer vaccine player — AstraZeneca fails to get type 1 diabetes FDA approval for Farxiga — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.Dismiss Notice
In the Pipe
This is a place to discuss all aspects of drugs in development. Often those in the field are a source of overlooked wisdom in assessing the value of a new drug. If this section becomes popular, it is possible that we may give it its own section on the site. Please feel free to post links to relevant information about new drugs. This board will currently allow anonymous posting, and posts will go live immediately. However, we do ask that you keep discussions on topic. Please understand that we will delete threads/posts that do not provide a useful discussion of new drugs in the pipeline.